Advancement in forensics is escalating the Asia-Pacific Biotechnology Market
Published: Sep 2020
Asia-Pacific biotechnology market is projected to grow at a significant CAGR of 7.1% during the forecast period (2020-2026). Rising crime cases and the adoption of forensics for solving the cases is considered one of the major factors which are augmenting the adoption of biotechnology in the region.
Awareness Programs for Mental Health will Continue Driving the US Schizophrenia Drugs Market
Published: Sep 2020
The US schizophrenia drugs market is projected to grow at a significant CAGR of 2.7% during the forecast period (2020-2026). The rising awareness programs for mental health is acting as one prominent factor in the market growth in the US. The first Wednesday in November each year is celebrated as National Stress Awareness Day in the US. Various programs are conducted on this day to create awareness related to the treatment available for the management of schizophrenia.
Established Mental Health Services Continue Driving UK Schizophrenia Drugs Market
Published: Sep 2020
UK schizophrenia drug market is projected to grow at a significant CAGR of around 2.7% during the forecast period (2020-2026). UK has a well-developed healthcare infrastructure with an established mental health facility. National Health Services (NHS) England spends $7.2 million per year on mental health services for ex-service personnel, in addition to the $12.7 billion spending on mental health for the general population, therefore, create significant market growth in the country.
Government Support for Anxiety Disorder will Continue Steering the North American Schizophrenia Drugs Market
Published: Sep 2020
North American schizophrenia drugs market is projected to grow at a significant CAGR of 2.1% during the forecast period (2020-2026). The increasing incidence of anxiety disorders in North America is generating the demand for different types of medication and therapies for its treatment and thereby is expected to propel the growth of the schizophrenia drugs market in the region.
Rising Schizophrenia in Female Population is Offering Steady Growth to Indian Schizophrenia Drugs Market
Published: Sep 2020
Indian schizophrenia drugs market is projected to grow at a significant CAGR of 4.0% during the forecast period (2020-2026). The major contributors in the market are the female population suffering from mental health issues in the country. There is no gender difference in schizophrenia; however, a stress and mental health are some factors leads to schizophrenia. In India, women face a lot of problems in India, especially in relation to pregnancy, marriage, childbirth, and menopause.
The Presence of Pronounced Mental Health Infrastructure is Escalating the European Schizophrenia Drugs Market
Published: Sep 2020
The European schizophrenia drug market is projected to grow at a significant CAGR of around 2.5% during the forecast period (2020-2026). The availability of considerable resources for mental health and a sophisticated healthcare system are other key factors that are expected to promote the growth of the market.
South Asia has a High Prevalence of Schizophrenia, Escalating the Asia-Pacific Schizophrenia Drugs Market
Published: Sep 2020
Asia-Pacific schizophrenia drugs market is projected to grow at a significant CAGR of 3.6% during the forecast period (2020-2026). In Asia-Pacific, the schizophrenia has a high prevalence in South Asian countries as compared to the rest of the region. According to the Progress in Mind, there are significantly different medication patterns preferred across South Asian countries.
Rising Development/Adoption of Advanced Medical Devices will Continue Steering the US
Published: Sep 2020
The US cardiovascular devices market is projected to grow at a significant CAGR of 6.2% during the forecast period (2020-2026). The rising awareness programs for CVD is acting as one prominent factor in the market growth in the US. Moreover, the presence of some of the key players in the US, such as Abbott Laboratories, Boston Scientific Corp., and Edwards Lifesciences Corp., is another factor contributing significantly in the growth of the US cardiovascular devices market.
Rising Awareness and Government Initiatives will Continue Steering UK Cardiovascular Devices Market
Published: Sep 2020
UK cardiovascular devices market is projected to grow at a significant CAGR of 5.0% during the forecast period (2020-2026). A significant prevalence of CVD in UK and the well-developed healthcare infrastructure are augmenting the demand for cardiovascular devices market. According to the British Heart Foundation, more than one-fourth of the fatalities in the UK occur due to CVD, and it is responsible for around 1.6 million fatalities each year.
Government in Itiatives and Steps to Cater CVD is Steering the North American Cardiovascular Devices Market
Published: Sep 2020
North American cardiovascular devices market is projected to grow at a significant CAGR of 5.6% during the forecast period (2020-2026). The market growth in North America can be attributed to the rising geriatric population, frequent US FDA approvals for innovative cardiovascular devices, and the growing adoption of minimally invasive/non-invasive cardiac surgeries.